Iovance Biotherapeutics (IOVA) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Iovance Biotherapeutics (IOVA) over the last 13 years, with Q3 2025 value amounting to $117.4 million.
- Iovance Biotherapeutics' Other Gross PP&E Adjustments fell 1826.31% to $117.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.4 million, marking a year-over-year decrease of 1826.31%. This contributed to the annual value of $49.0 million for FY2024, which is 359.71% down from last year.
- According to the latest figures from Q3 2025, Iovance Biotherapeutics' Other Gross PP&E Adjustments is $117.4 million, which was down 1826.31% from $102.9 million recorded in Q2 2025.
- Iovance Biotherapeutics' Other Gross PP&E Adjustments' 5-year high stood at $143.6 million during Q3 2024, with a 5-year trough of $49.0 million in Q4 2024.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was $68.2 million (2023), whereas its average is $83.6 million.
- Per our database at Business Quant, Iovance Biotherapeutics' Other Gross PP&E Adjustments skyrocketed by 12594.65% in 2024 and then tumbled by 2320.79% in 2025.
- Quarter analysis of 3 years shows Iovance Biotherapeutics' Other Gross PP&E Adjustments stood at $50.8 million in 2023, then dropped by 3.6% to $49.0 million in 2024, then skyrocketed by 139.66% to $117.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at $117.4 million for Q3 2025, versus $102.9 million for Q2 2025 and $82.8 million for Q1 2025.